Review: Photobiomodulation Therapy can be used for Age-Relat
Photobiomodulation therapy (PBT) has emerged as a possible treatment for age-related macular degeneration (AMD) and diabetic retinopathy (DR). This review seeks to summarize the application of PBT in AMD and DR.

--14 studies examining the application of PBT for AMD and 9 studies examining the application of PBT for diabetic macular edema (DME) were extracted from 60 candidate publications.

Despite notable methodological differences between studies, PBT has been reported to treat certain DR and AMD patients. DR patients with center involving DME and VA more than 20/25 have demonstrated response to treatment.

--AMD patients at Age-Related Eye Disease Study Stages 2– 4 with VA more than 20/200 have also shown response to treatment.

PBT remains an emergent therapy with possible applications in DR and AMD.